Aemetis (NASDAQ:AMTX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Key Points

• Aemetis reported a quarterly loss of ($0.41) earnings per share (EPS), missing the consensus estimate of ($0.35) by ($0.06).
• The company generated revenue of $52.24 million, significantly lower than analysts' expectations of $78.68 million.
• Aemetis received a price target upgrade from UBS Group, raising their target from $2.20 to $3.00 and maintaining a "buy" rating.

Aemetis (NASDAQ:AMTX - Get Free Report) announced its earnings results on Thursday. The specialty chemicals company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.06), Zacks reports. The firm had revenue of $52.24 million for the quarter, compared to analysts' expectations of $78.68 million.

Aemetis Stock Performance

Aemetis stock traded up $0.25 during trading hours on Friday, hitting $2.67. The company had a trading volume of 1,116,616 shares, compared to its average volume of 942,119. The firm has a market cap of $147.84 million, a P/E ratio of -1.65 and a beta of 1.49. Aemetis has a 1 year low of $1.22 and a 1 year high of $4.73. The company has a 50-day moving average price of $2.57 and a two-hundred day moving average price of $2.04.

Institutional Investors Weigh In On Aemetis

An institutional investor recently bought a new position in Aemetis stock. Creative Planning acquired a new position in Aemetis, Inc (NASDAQ:AMTX - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 12,185 shares of the specialty chemicals company's stock, valued at approximately $30,000. Hedge funds and other institutional investors own 27.02% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AMTX shares. UBS Group upped their price target on shares of Aemetis from $2.20 to $3.00 and gave the company a "buy" rating in a report on Monday, June 30th. Ascendiant Capital Markets upped their price target on shares of Aemetis from $19.00 to $20.00 and gave the company a "buy" rating in a report on Friday, June 6th.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.